Volume 58, Issue 5, Pages (November 2000)

Slides:



Advertisements
Similar presentations
Spotlight on general principles of hemodialysis
Advertisements

Volume 66, Issue 6, Pages (December 2004)
Volume 54, Issue 2, Pages (August 1998)
Hemodialyzer: From macro-design to membrane nanostructure; the case of the FX- class of hemodialyzers  Claudio Ronco, Sudhir Kumar Bowry, Alessandra Brendolan,
Linear and logistic regression analysis
Tuberculosis and tubulointerstitial nephritis: an intriguing puzzle
Downloadable computer models for renal replacement therapy
Volume 66, Issue 4, Pages (October 2004)
Tariq Shafi, Andrew S. Levey  Advances in Chronic Kidney Disease 
Elaine M. Spalding, Paul W. Chamney, Ken Farrington 
Alex Castellarnau, Michael Werner, Roman Günthner, Marten Jakob 
Determinants of phosphorus mobilization during hemodialysis
Volume 54, Issue 3, Pages (September 1998)
Clinical Practice Guidelines for Hemodialysis Adequacy, Update 2006
Continuous Dialysis Therapies: Core Curriculum 2016
Volume 68, Issue 5, Pages (November 2005)
Volume 55, Issue 2, Pages (February 1999)
Fibrin plug Kidney International Volume 78, Issue 9, (November 2010)
Volume 67, Issue 2, Pages (February 2005)
Volume 88, Issue 2, Pages (August 2015)
Better nephrology for mice—and man
Volume 77, Issue 8, Pages (April 2010)
Is there a pharmacologic basis for combination renin axis blockade?
Effects of a reduced inner diameter of hollow fibers in hemodialyzers
Continuous Renal Replacement Therapy
Volume 78, Issue 6, Pages (September 2010)
Volume 14, Issue 11, Pages (November 2017)
Pasquale Esposito, Teresa Rampino, Giuseppe Sileno, Antonio Dal Canton 
Volume 67, Issue 4, Pages (April 2005)
How to interpret the eGFR in patients with small body surface area
Volume 53, Issue 4, Pages (April 1998)
Volume 70, Issue 2, Pages (July 2006)
Multicompartment urea kinetics in well-dialyzed children
Volume 64, Issue 1, Pages (July 2003)
Volume 87, Issue 2, Pages (February 2015)
Predilution hemodiafiltration displays no hemodynamic advantage over low-flux hemodialysis under matched conditions  Nikolaos Karamperis, Erik Sloth,
Blood pressure targets in hemodialysis patients
Volume 60, Issue 4, Pages (October 2001)
Effects of a reduced inner diameter of hollow fibers in hemodialyzers
Hemodialysis arteriovenous access: Detection of stenosis and response to treatment by vascular access blood flow  Steve J. Schwab, Matthew J. Oliver,
Volume 78, Issue 8, Pages (October 2010)
Volume 76, Issue 6, Pages (September 2009)
Volume 67, Issue 1, Pages (January 2005)
On-line mixed hemodiafiltration with a feedback for ultrafiltration control: Effect on middle-molecule removal  Luciano A. Pedrini, Vincenzo De Cristofaro 
A fractional dialysate collection method to estimate solute removal in continuous venovenous hemodialysis  Nigel S. Kanagasundaram, A. Brett Larive, Emil.
Guillaume Jean, Bernard Charra, Charles Chazot, Guy Laurent 
Renovascular adaptive changes in chronic hypoxic polycythemia
Volume 68, Issue 4, Pages (October 2005)
Clearance and removal of oxalate in children on intensified dialysis for primary hyperoxaluria type 1  F. Illies, K.-E. Bonzel, A.-M. Wingen, K. Latta,
Volume 60, Issue 4, Pages (October 2001)
A man with a hole in his penis
Volume 60, Issue 2, Pages (August 2001)
Joachim Böhler, M.D., Johannes Donauer, Frieder Keller 
Volume 71, Issue 11, Pages (June 2007)
Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study1  Robert N. Foley, Charles A. Herzog, Allan J.
Volume 70, Issue 10, Pages (November 2006)
The course of the remnant kidney model in mice
Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms  Bert Bammens, Pieter Evenepoel, Kristin.
Volume 80, Issue 10, Pages (November 2011)
Volume 80, Issue 10, Pages (November 2011)
Volume 80, Issue 10, Pages (November 2011)
The hypothesis that abnormal BH4 metabolism impairs kidney function
Manuel Prado, Laura M. Roa, Alfonso Palma, Jose A. Milen 
Volume 73, Issue 6, Pages (March 2008)
The removal of uremic toxins
Volume 69, Issue 3, Pages (February 2006)
Glomerular filtration rate via plasma iohexol disappearance: Pilot study for chronic kidney disease in children  G.J. Schwartz, S. Furth, S.R. Cole, B.
Rebound kinetics of β2-microglobulin after hemodialysis
Volume 57, Issue 4, Pages (April 2000)
Volume 56, Issue 3, Pages (September 1999)
Presentation transcript:

Volume 58, Issue 5, Pages 2155-2165 (November 2000) Mixed predilution and postdilution online hemodiafiltration compared with the traditional infusion modes  Luciano A. Pedrini, Vincenzo De Cristofaro, Bruno Pagliari, Francesco Samà  Kidney International  Volume 58, Issue 5, Pages 2155-2165 (November 2000) DOI: 10.1111/j.1523-1755.2000.00389.x Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 1 Mean instantaneous dialyzer clearances at 60, 120, and 180 minutes during the sessions. The general linear model ANOVA for repeated measurements was used. Treatment effect for urea (U), creatinine (Cr), and phosphate (Phos), P < 0.0001; for β2m, P = 0.054. Time effect for U, P < 0.01; for β2m, P < 0.001; for Cr and Phos, P = NS. Treatment × time effect (interactions), P = NS. Post-hoc tests (significance at P < 0.05). Treatment effect: a, pre-HDF vs. post-HDF; c, pre-HDF vs. mixed HDF. Symbols are: (▪) HDF; (▵) mixed HDF; (•) pre-HDF. Kidney International 2000 58, 2155-2165DOI: (10.1111/j.1523-1755.2000.00389.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 2 β2-microglobulin (β2m) removal, evaluated from the blood side (▪), and by direct quantitation in dialysate . The white columns (□) represent the protein extracellular pool prior to the sessions (discussed in the text). Negative values may be assumed to be representative of the amount of β2m adsorbed by the membrane (; one-way ANOVA, P = NS). Kidney International 2000 58, 2155-2165DOI: (10.1111/j.1523-1755.2000.00389.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 3 Mean effective clearances and urea equilibrated dialysis dose (eKt/V) of the sessions, according to the modified direct quantitation (mDQ) method. One-way ANOVA for: (□) urea, P = 0.004; creatinine, P = 0.041; β2m and (▪) phosphate, P = NS. P < 0.05, pre-HDF vs. post-H, post hoc tests. For eKt/V, P = 0.007. aP < 0.05, pre-HDF vs. post-HDF, post hoc tests. Kidney International 2000 58, 2155-2165DOI: (10.1111/j.1523-1755.2000.00389.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 4 Increase in mean hematocrit (A) and plasma total proteins (B) during the passage of blood through the dialyzer. Values at the start and the end of the sessions are also shown. One-way ANOVA for prefilter and postfilter hematocrit (Hct) and total protein, P < 0.0001. Post hoc tests (significance at P < 0.05): (a) pre-HDF vs. post HDF; (b) mixed HDF vs. post-HDF; (c) mixed HDF vs. pre-HDF. Symbols are: (▪) post-HDF; (▵) mixed HDF; (•) pre-HDF. Kidney International 2000 58, 2155-2165DOI: (10.1111/j.1523-1755.2000.00389.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 5 Mean ultrafiltration coefficient of the dialyzer (A) and apparent β2m sieving coefficient (B) during the pilot sessions with different infusion modes. The general linear model ANOVA for repeated measures was used. Treatment effect for Kuf, P < 0.0001; for β2m sieving coefficient, P = NS. Time effect for Kuf, P < 0.0001; for β2m sieving coefficient, P = 0.002. Post hoc tests are as discussed in Figure 4. Symbols are: (▪) post-HDF; (▵) mixed HDF; (•) pre-HDF. Kidney International 2000 58, 2155-2165DOI: (10.1111/j.1523-1755.2000.00389.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 6 Mean trans membrane pressure (TMP) gradients recorded during the three infusion modes: (□) pre-HDF; (?) mixed HDF; (▪) post-HDF. Kidney International 2000 58, 2155-2165DOI: (10.1111/j.1523-1755.2000.00389.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 7 Relationship between the mean TMPmax value and the mean filtration fraction (FF) of the sessions. TMPmax = 11.055 × EXP (7.085 × FF), R2 = 0.8775, P < 0.0001. Kidney International 2000 58, 2155-2165DOI: (10.1111/j.1523-1755.2000.00389.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 8 Best fitting curves (polynomial second order) relating the instantaneous dialyzer clearances (KI) of (A) urea, (B) creatinine, and (C) β2m (full pattern, scale on the left y axis) with FF. Analysis was performed on the pooled data of the three infusion modes. Plotted points are only differentiated graphically according to the infusion mode [(▪) post-HDF, (▴) mixed HDF, (•) pre-HDF]. The superimposed dashed curve represents the relationship between TMPmax of the sessions (scale on the right y axis) and FF (depicted in Figure 7; discussed in the text). KI urea = 121.7 + 509.3 × FF - 445.2 × FF2, R2 = 0.41, P < 0.001. Runs tests: P = 0.18 (NS). KI creatinine = 4.55 + 707.1 × FF - 690.5 × FF2, R2 = 0.37, P < 0.001. Runs tests: P = 0.07 (NS). KIβ2m = 13.3 + 354.9 × FF - 292.5 × FF2, R2 = 0.27, P < 0.005. Runs tests: P = 0.74 (NS). Kidney International 2000 58, 2155-2165DOI: (10.1111/j.1523-1755.2000.00389.x) Copyright © 2000 International Society of Nephrology Terms and Conditions